These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1892033)

  • 61. Yersinia enterocolitica ileocolitis in beta-thalassemic patients.
    Greco L; Marino F; Gentile A; Catalano G; Angilletta D
    Colorectal Dis; 2006 Jul; 8(6):525. PubMed ID: 16784477
    [No Abstract]   [Full Text] [Related]  

  • 62. Yersinia pseudotuberculosis septicaemia in thalassaemia major.
    Gordts B; Rummens E; deMeirleir L; Butzler JP
    Lancet; 1984 Jan; 1(8367):41-2. PubMed ID: 6140358
    [No Abstract]   [Full Text] [Related]  

  • 63. Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients.
    Cherchi GB; Cossellu S; Pacifico L; Gallisai D; Ranucci A; Zanetti S; Fadda G; Chiesa C
    Contrib Microbiol Immunol; 1995; 13():16-8. PubMed ID: 8833786
    [No Abstract]   [Full Text] [Related]  

  • 64. [Yersinia enterocolitica sepsis in splenectomized thalassemic subjects. Description of 2 cases].
    Rasore-Quartino A; Mattiello A; Cominetti M; Casini Lemmi M; Traverso T; Sansone G
    Pediatr Med Chir; 1986; 8(1):121-4. PubMed ID: 3725604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Yersinia enterocolitica contamination of blood products. Connecticut State Medical Society Committee on Organ and Tissue Transfers.
    Badon SJ; Cable RG
    Conn Med; 1992 Jun; 56(6):287-9. PubMed ID: 1638859
    [No Abstract]   [Full Text] [Related]  

  • 66. Clinical challenges and images in GI. Yersinia enterocolitica mesenteric adenitis and terminal ileitis.
    Fuchizaki U; Machi T; Kaneko S
    Gastroenterology; 2006 Nov; 131(5):1379, 1659. PubMed ID: 17128504
    [No Abstract]   [Full Text] [Related]  

  • 67. The pathogenesis of Yersinia enterocolitica gastroenteritis.
    Robins-Browne RM; Jansen van Vuuren CJ; Still CS; Miliotis MD; Koornhof HJ
    Contrib Microbiol Immunol; 1979; 5():324-8. PubMed ID: 394919
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Yersinia enterocolitica infection in thalassemia. Report of one case (author's transl)].
    Balestrazzi P; Banchini G; Menozzi MG; Frassi C; De Angelis GL; Giovannelli G
    Pediatr Med Chir; 1981; 3(4):269-71. PubMed ID: 6979742
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusion--United States, 1987-1988.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(37):577-8. PubMed ID: 3137444
    [No Abstract]   [Full Text] [Related]  

  • 71. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Yersinia enterocolitica gastroenteritis among infants exposed to chitterlings--Chicago, Illinois, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(40):956-8. PubMed ID: 14534510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Yersinia enterocolitica septicemia and primary hemochromatosis. Discussion of the promoting role of iron overload].
    Jacquenod P; Poitrine A; Loiseau D; Naveau S
    Gastroenterol Clin Biol; 1984 Mar; 8(3):293-4. PubMed ID: 6714567
    [No Abstract]   [Full Text] [Related]  

  • 74. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Human infection caused by Yersinia pseudotuberculosis (Malassez and Vignal bacillus) and Yersinia enterocolitica].
    Toscano F
    G Mal Infett Parassit; 1969 Mar; 21(3):217-20. PubMed ID: 5380346
    [No Abstract]   [Full Text] [Related]  

  • 76. [Extensive character of human infections with Yersinia enterocolitica].
    Rusu V; Lucinescu S
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):197-205. PubMed ID: 757659
    [No Abstract]   [Full Text] [Related]  

  • 77. [Clinical aspects, pathogenesis and treatment of Yersinia infections].
    Iushchuk ND; Karetkina GN; Proskurina LN; Malov IV; Via'lba EV
    Klin Med (Mosk); 1989 May; 67(5):91-7. PubMed ID: 2671487
    [No Abstract]   [Full Text] [Related]  

  • 78. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function.
    Marciani MG; Cianciulli P; Stefani N; Stefanini F; Peroni L; Sabbadini M; Maschio M; Trua G; Papa G
    Haematologica; 1991; 76(2):131-4. PubMed ID: 1937171
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Food microbiology update. Emerging foodborne pathogens.
    Bryant RG
    Appl Biochem Biotechnol; 1983 Oct; 8(5):437-54. PubMed ID: 6383214
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bacterial shock due to transfusion with Yersinia enterocolitica infected blood.
    Bjune G; Ruud TE; Eng J
    Scand J Infect Dis; 1984; 16(4):411-2. PubMed ID: 6528227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.